General Information
Allergan Overactive Bladder 004
A Multi-Center, Double-blind, Placebo-controlled Trials of Sanctura® XR 60mg Daily in Female OAB Patients on Multiple Concomitant Medications Refractory to Detrol LA 4mg Daily
| Protocol | GMA-SXR-09-004 |
|---|---|
| Identifier | GMA-SXR-09-004 |
| UID | f87c3c04-6e18-4d68-ac66-df30e2f8d097 |
| Status | Done - Archived |
| Phase | 3 |
| Category | Overactive Bladder / Adult |
| Launch Year | 2010 |
| NCT Number | - |
| Created | 2010-09-21 12:54 |
| Last Updated | 2010-09-21 12:54 |
Description
Key Elements: Study drug Sanctura® XR 60mg (similar to Detrol® LA) or placebo. Study drug administration will be one tablet one hour before a meal once daily 14 Weeks/7 Visits (1 Screening Visit, 5 Treatment Visits, 1 follow-up visit). $25 per visit.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | 2011-05-31 | No |
| Enrollment Open | 2010-12-28 | No |
| First Patient First Visit | No | |
| Site Initiation Mtg. | No | |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2012-09-19 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Elias, Emilia | EElias | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Allergan |
|---|---|
| Division | Allergan |
| Team | Allergan |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gainsboro |
| Currency | - |
